- Betta receives exclusive license of balstilimab (anti-PD-1) and zalifrelimab (anti-CTLA-4) in Greater China ...
SINGAPORE – A new framework is seeking to avert the extinction of 90 critically endangered freshwater fish species, including the Betta fish, in South-east Asia. The Strategic Framework to Accelerate ...
June 22 (Reuters) - Betta Pharmaceuticals Co Ltd : * SAYS IT AGREES TO OBTAIN COMMERCIALIZATION RIGHTS FOR AGENUS' BALSTILIMAB AND ZALIFRELIMAB IN MAINLAND CHINA, HONG KONG, MACAU AND TAIWAN Keep up ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback